Literature DB >> 10207001

A human papillomavirus E2 transcriptional activator. The interactions with cellular splicing factors and potential function in pre-mRNA processing.

M C Lai1, B H Teh, W Y Tarn.   

Abstract

The human papillomavirus (HPV) E2 protein plays an important role in transcriptional regulation of viral genes as well as in viral DNA replication. Unlike most types of HPV, the E2 protein of epidermodysplasia verruciformis (EV)-associated HPVs harbors a relatively long hinged region between the terminal, conserved transactivation and DNA binding/dimerization domains. The sequence of EV-HPV E2 hinge contains multiple arginine/serine (RS) dipeptide repeats which are characteristic of a family of pre-messenger RNA splicing factors, called SR proteins. Here we show that the HPV-5 (an EV-HPV) E2 protein can specifically interact with cellular splicing factors including a set of prototypical SR proteins and two snRNP-associated proteins. Transiently expressed HPV-5 E2 protein colocalizes with a nuclear matrix associated-splicing coactivator in nuclear speckled domains. The RS-rich hinge is essential for E2 transactivator interaction with splicing factors and for its subnuclear localization. Moreover, we present functional evidence for the HPV-5 E2 transactivator, which shows that the RS-rich hinge domain of the E2 protein can facilitate the splicing of precursor messenger RNA made via transactivation by E2 itself. Our results, therefore, suggest that a DNA binding transactivator containing an RS-rich sequence can play a dual role in gene expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10207001     DOI: 10.1074/jbc.274.17.11832

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

Review 1.  Multiple links between transcription and splicing.

Authors:  Alberto R Kornblihtt; Manuel de la Mata; Juan Pablo Fededa; Manuel J Munoz; Guadalupe Nogues
Journal:  RNA       Date:  2004-10       Impact factor: 4.942

2.  The WW domain-containing proteins interact with the early spliceosome and participate in pre-mRNA splicing in vivo.

Authors:  Kai-Ti Lin; Ruei-Min Lu; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

3.  DDX3 regulates cell growth through translational control of cyclin E1.

Authors:  Ming-Chih Lai; Wen-Cheng Chang; Sheau-Yann Shieh; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2010-09-13       Impact factor: 4.272

Review 4.  Importin KPNA2, NBS1, DNA repair and tumorigenesis.

Authors:  Shu-Chun Teng; Kou-Juey Wu; Shun-Fu Tseng; Chui-Wei Wong; Li Kao
Journal:  J Mol Histol       Date:  2006-06-03       Impact factor: 2.611

Review 5.  A subset of nuclear receptor coregulators act as coupling proteins during synthesis and maturation of RNA transcripts.

Authors:  Didier Auboeuf; Dennis H Dowhan; Martin Dutertre; Natalia Martin; Susan M Berget; Bert W O'Malley
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

Review 6.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

Review 7.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

8.  Interferon regulatory factor 1 and a variant of heterogeneous nuclear ribonucleoprotein L coordinately silence the gene for adhesion protein CEACAM1.

Authors:  Kenneth J Dery; Craig Silver; Lu Yang; John E Shively
Journal:  J Biol Chem       Date:  2018-05-02       Impact factor: 5.157

9.  Nuclear Pnn/DRS protein binds to spliced mRNPs and participates in mRNA processing and export via interaction with RNPS1.

Authors:  Chin Li; Ru-Inn Lin; Ming-Chih Lai; Pin Ouyang; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites.

Authors:  Sohrab Bodaghi; Rong Jia; Zhi-Ming Zheng
Journal:  Virology       Date:  2009-02-01       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.